Myomo (MYO) Cost of Revenue (2016 - 2025)

Myomo has reported Cost of Revenue for 10 years, with the latest figure at $5.3 million in Q3 2025.

• For the quarter ending Q3 2025, Cost of Revenue rose 54.48% year-over-year to $5.3 million; the trailing twelve-month figure through Sep 2025 stood at $18.3 million (up 185.58% YoY), and the FY2024 full-year result was $9.4 million, up 54.58% from the prior year.
• Cost of Revenue for Q3 2025 stood at $5.3 million, roughly flat from $5.2 million in the prior quarter.
• The five-year high for Cost of Revenue was $5.3 million in Q3 2025, with the low at -$630803.0 in Q4 2023.
• Historically, Cost of Revenue has averaged $2.1 million across 5 years, with a median of $1.4 million in 2022.
• Annual changes were most pronounced in 2023 — Cost of Revenue tumbled 144.61% — and 2024, when it soared 647.43%.
• Myomo's Cost of Revenue stood at $909175.0 in 2021, then soared by 55.52% to $1.4 million in 2022, then plunged by 144.61% to -$630803.0 in 2023, then soared by 647.43% to $3.5 million in 2024, then soared by 52.15% to $5.3 million in 2025.
• The last three Cost of Revenue figures came in at $5.3 million (Q3 2025), $5.2 million (Q2 2025), and $4.4 million (Q1 2025), per Business Quant data.